InvestorsHub Logo
icon url

Wisdom of Locke

04/14/22 3:08 PM

#147314 RE: pumper_stumper #147305

Old news. These shares have been issued since the transaction and were what was used to pay for the IP, monoclonal antibodies, AI, 17 new patents. They have been available to be converted for over a year and a half.

What's the point? Looks like the audit had more to do with it than any claim about secret SEC access. LMAO.

To me, this just proves that management has a (welcome) long view of the value of ENZC as they took shares (not cash) for all their patented antibody and other cutting edge technology products.